ClinicalTrials.gg
CompletedNCT00612391HURAUpdated Apr 30, 2021

Lateral Mini Approach vs Anterior Approach for Plating of Proximal Humerus Fracture

An interventional study of Lateral minimally invasive approach (plate fixation) and Deltopectoral approach (plate fixation) in Closed Fracture Proximal Humerus, Neck, sponsored by Université de Montréal. Completed at 1 site in Canada. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2021-04-30.

Sponsored by Université de Montréal · Not applicable, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
79
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

A prospective randomized clinical trial is proposed to compare the plate fixation of proximal humerus fractures using a minimally invasive lateral approach and the traditional anterior approach.Forty five patients will be assigned to each approach (total of 90 patients) and will be assessed 7 times over a two-year period. The trial's primary objectives will be to demonstrate the efficacy of the plating technique in terms of speed of recuperation of function. The Quick DASH will be used for evaluation of function.The study will also examine secondary end-points of pain, range of motion, esthetic satisfaction and radiographic outcome, as assessed by the components of the Constant Score3,4, SF-12V2 Questionnaire, and Patient Scare Assessment Scale Questionnaire. Furthermore, the assessment of safety will be based on the rates of all reported complications and adverse events at 2 years

02

Conditions studied

  • Closed Fracture Proximal Humerus, Neck

Browse trials for

Keywords

  • humerus fracture
03

In context

Humeral Fractures

106 studies on the registry are indexed under Humeral Fractures; 20 are open to participants now.

This study's enrollment of 79 is above the median of 56 across 64 interventional studies indexed under Humeral Fractures.

Browse Humeral Fractures studies →

Lead sponsor

Université de Montréal is the lead sponsor of 98 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Humeral surgical neck fracture, Neer II valgus-type Neer III
  2. Patient willing to participate in the study
  3. Patient available for follow-up through at least two years
  4. Patient with acceptable preoperative medical clearance and free of, or treated for, medical conditions that would pose excessive operative risk
  5. Patient fluent in French and/or English and able to understand his/her role in the study

Exclusion criteria

Exclusion Criteria:

  1. Inflammatory arthritis
  2. Prior shoulder pathology
  3. Active local or systemic infection
  4. Neurologic or musculoskeletal disease that may adversely affect mobility
  5. Participation in any other pharmaceutical, biologic or medical-device clinical investigation
  6. Severe documented psychiatric disease
  7. Severe ipsilateral elbow or wrist disease
  8. Fracture resistant to reduction attempts through the minimally invasive lateral approach
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
79 participants (actual)

Study arms

  • Experimental
    Lateral, Minimally Invasive Approach

    Lateral, Minimally Invasive Approach in GT fractures treated operatively (plates and screws)

    Procedure: Lateral minimally invasive approach (plate fixation)

  • Active comparator
    Deltopectoral approach:

    Deltopectoral approach for GT fracture treated operatively

    Procedure: Deltopectoral approach (plate fixation)

Interventions

  • ProcedureLateral minimally invasive approach (plate fixation)

    A longitudinally oriented, 4-cm incision will be made laterally starting at the acromion. The deltoid will be split proximally at the most strategic location (vis-à-vis the fracture), and after the deltoid is bluntly elevated from the humerus more distally the axillary nerve will be identified by digital palpation. The nerve is easily identified posteriorly as it emerges from the quadrilateral space. With a finger maintained on the nerve for protection, the plate will be inserted onto the lateral side of the proximal humerus and fixed according to the described technique. A second, 2-cm longitudinal incision will then be made further distally for diaphyseal screw placement. This incision is well distal to the course of the axillary nerve.

  • ProcedureDeltopectoral approach (plate fixation)

    Anterior, Delto-Pectoral Approach - A 10-cm incision will be made over the deltopectoral groove, starting at the coracoid process proximally. As the clavipectoral fascia is incised, the cephalic vein will be identified and retracted laterally with the deltoid muscle. The pectoralis major as well as the conjoint tendon will be retracted medially, and the long head of the biceps tendon will be identified and used as a guide for achieving an anatomic reduction of the different fracture parts. Next, internally rotating the humerus will allow access to the lateral side of the proximal humerus, on which the plate will then be fixed according to the described technique.

06

What researchers measure

Primary outcomes

  1. Quick DASH

    Time frame: 3, 6, and 12 weeks, and at 6, 12, 18 and 24 months.

Secondary outcomes

  1. SF-12V2 Questionnaire Constant Shoulder Score The Patient Scar Assessment Scale Complication rate

    Time frame: 3, 6, and 12 weeks, and at 6, 12, 18 and 24 months.

07

Study locations

1 site
  • Hopital Sacré-Coeur
    Montreal, Quebec H4J1C5, Canada
08

References and documents

Publications

  • Handoll HH, Elliott J, Thillemann TM, Aluko P, Brorson S. Interventions for treating proximal humeral fractures in adults. Cochrane Database Syst Rev. 2022 Jun 21;6(6):CD000434. doi: 10.1002/14651858.CD000434.pub5. PubMed 35727196 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Nov 2007, a primary completion of Jul 2019 and a completion of Nov 2020. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 29, 2008
First posted
Feb 11, 2008
Start
Nov 2007
Primary completionActual
Jul 2019
CompletionActual
Nov 2020
Last update
Apr 30, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 30, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00612391
Lead sponsor
Université de Montréal
Collaborators
Centre de recherche du Centre hospitalier universitaire de Sherbrooke, Hopital du Sacre-Coeur de Montreal
Responsible party
Dominique Rouleau (Orthopaedic surgeon, Université de Montréal) — Principal investigator
First posted
Feb 11, 2008
Start date
Nov 2007
Primary completion
Jul 2019
Completion
Nov 2020
Last update
Apr 30, 2021

Study contacts

Dominique M Rouleau, MD
principal investigator · Hopital Sacré-Coeur

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion